Drug shortages in the US are critically impactful on patient care. What are the solutions?

Prescription drug shortages are a significant concern in the United States, affecting patient outcomes dramatically by delaying and canceling procedures and treatments. Hospitals increasingly face difficulty finding antibiotics, chemotherapy drugs, and other lifesaving medications for patients. This problem is widespread across the US, with hospitals running low on drugs like corticosteroids, ADHD medications, injectable opioids and even oral liquids like amoxicillin and ibuprofen.

This requires effective solutions as soon as possible, but until the issue is resolved, hospitals are looking for alternative treatments for patients who qualify for them. Professionals in the health system and pharmaceutical industry know how to adapt and replace treatments if necessary; however, they are showing significant concerns over how the shortage of drugs is affecting patients. Given the complexity of the problem, it is evident that no quick fixes should be expected. However, drug shortages could dramatically impact the US healthcare system if action isn’t taken as soon as possible.

Image source: https://www.freepik.com/free-photo/medicine-capsules-global-health-with-geometric-pattern-digital-remix_17226007.htm#query=drug&position=2&from_view=search&track=sph

What are the reasons behind the drug shortage crisis in the US?

According to a report, drug shortages in the US have seen a rise of nearly 30% in 2021-2022. As the report showed, it’s already been more than a decade since critical drug products experienced a shortage that was never resolved. Unfortunately, this problem has been constant for decades, and although the increased demand is a reason for this issue, it’s by no means the only one. The way drugs are manufactured and sold for the market in the United States is also part of the issue. Drug manufacturing involves a complex global supply chain. Any disruptions that occur during the process – whether related to geopolitical factors, natural disasters, or manufacturing issues- can cause drug shortages. For instance, many disruptions during the COVID-19 pandemic had a major impact on pharmaceutical production and distribution.

Economic factors, like the manufacturing cost, as well as market demand and profitability, also impact the production of drugs. The pharma industry is focused on profit maximization, so if a drug isn’t profitable to produce, they may choose to discontinue it or use their resources to develop more profitable products – this particularly applies to generic drugs with lower profit margins. However, this significantly impacts patients’ health, so it needs to be addressed by balancing profit motives with patients’ needs.

Many drugs rely on raw ingredients and materials, and if there is a shortage of these materials, the production of drugs is inevitably disrupted. This is especially true for generic drugs, as they rely on a few suppliers only. It’s crucial to diversify suppliers and source raw materials locally whenever possible to lower the risk of supply chain disruptions.

Improving patient outcomes: What role does pharmaceutical market research play?

The pharmaceutical industry is undoubtedly a complex one, with professionals being committed to effectively addressing patient needs. However, meeting those needs isn’t possible without a deep understanding of the pharmaceutical industry. That’s where pharma and life science research can help, allowing companies in the sector to solve the problem of drug shortages. Market research is paramount in addressing the drug shortage problem in the US because it provides valuable insights into the industry. As a result, companies can understand all the factors that lead to drug shortages and ensure a more reliable supply chain that benefits patient care. However, this can be a complex process, as it involves many steps. Firstly, companies must begin by identifying drug demand patterns through historical data analysis, which allows them to anticipate demand fluctuations and better prepare for potential shortages.

Furthermore, market research enables pharmaceutical companies to spot future healthcare trends and allocate their resources effectively to ensure they can meet demand by providing a steady supply of drugs. Given that supply chain issues are one of the main causes behind drug shortages, it’s essential to take advantage of market research to assess potential risks and vulnerabilities and then take the necessary action to prevent disruptions in production facilities or raw materials supply. Pharmaceutical market research also plays a role in enhancing product development and optimizing the pricing of drugs, which can result in the growth of the pharma sector and, most importantly, in better patient care, which is so necessary.

What other solutions could help mitigate drug shortages in the US?

Drug shortages aren’t an issue that can be solved overnight. Given its complexity, it requires collaborative efforts from stakeholders such as healthcare providers, pharma companies, policymakers and regulatory agencies. Some of the solutions that could help prevent drug shortages include:

• Diversifying the supply chain process instead of relying on a unique supplier for raw materials and vital drugs, as this could reduce the impact of disruptions;
• Regulatory flexibility from agencies who could accelerate approvals for changes in drug manufacturing or sourcing if there is an emergency or a critical shortage;
• Encouraging reserve production capacity, namely ensuring there’s a reserve of drugs that will help meet unexpected demand increases or disruptions;
• Ensuring that manufacturing facilities meet regulatory compliance and follow high-quality standards to prevent production interruption risks;
• Providing transparency regarding the pricing of drugs, which could help reduce market distortions;
• Investing in research and development to create alternative production methods for essential drugs to no longer rely on specific suppliers;
• Developing emergency response plans at all healthcare systems’ levels to ensure adequate response when there is an unexpected drug shortage.

These are just a few solutions that can be implemented to solve drug shortages, but the list isn’t comprehensive. It’s worth noting that this is an ongoing process, and the focus should be on both short-term and long-term strategies – a combination of the two is necessary to ensure all medications are available to patients. All stakeholders should stay vigilant and work together to prevent drug shortages from putting patients’ lives at risk.

Takeaway

Data shows that there are shortages for above 300 drugs in the United States – and cancer patients are the most affected by this issue. The effects of drug shortages are widespread and dramatic, and it’s necessary to look for solutions to prevent this ongoing problem. This can only be possible through collaborative efforts and a shift from being reactive to being proactive, and investing in strategies that can ensure better drug manufacturing quality and a more resilient system.

Share on Facebook

Tweet

Follow us